YorkBridge Wealth Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $421K | Sell |
3,702
-333
| -8% | -$37.9K | 0.11% | 144 |
|
|
2022
Q3 | $250K | Buy |
4,035
+351
| +10% | +$21.7K | 0.06% | 233 |
|
|
2022
Q2 | $294K | Sell |
3,684
-161
| -4% | -$12.8K | 0.08% | 201 |
|
|
2022
Q1 | $405K | Sell |
3,845
-97
| -2% | -$10.2K | 0.09% | 174 |
|
|
2021
Q4 | $425K | Buy |
3,942
+60
| +2% | +$6.47K | 0.1% | 174 |
|
|
2021
Q3 | $425K | Buy |
3,882
+167
| +4% | +$18.3K | 0.11% | 148 |
|
|
2021
Q2 | $348K | Buy |
3,715
+16
| +0.4% | +$1.5K | 0.09% | 182 |
|
|
2021
Q1 | $340K | Buy |
+3,699
| New | +$340K | 0.1% | 172 |
|
|
2019
Q3 | – | Sell |
-365
| Closed | -$9K | – | 758 |
|
|
2019
Q2 | $9K | Sell |
365
-196
| -35% | -$4.83K | ﹤0.01% | 599 |
|
|
2019
Q1 | $15K | Sell |
561
-484
| -46% | -$12.9K | 0.01% | 510 |
|
|
2018
Q4 | $20K | Sell |
1,045
-251
| -19% | -$4.8K | 0.01% | 469 |
|
|
2018
Q3 | $24K | Buy |
+1,296
| New | +$24K | 0.01% | 488 |
|